Theratechnologies Long Term Debt

Theratechnologies (THTX) currently reports a long-term debt of $40M as of May 2025. That compares with $41M in the prior-year period — down 2.6% year over year. Use the charts on this page to explore Theratechnologies's long-term debt history and peer comparisons.

Theratechnologies's long-term debt decreased from $41M to $40M — a 2.6% year-over-year decrease (period ending May 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theratechnologies reported $40M in long-term debt as of May 2025. That compares with $41M in the prior-year period — down 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theratechnologies, and consider following THTX for alerts when major investors trade the stock.

Theratechnologies is classified in the Healthcare sector. On long-term debt, it currently shows $40M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THTX with unrelated industries.